A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
PURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.
Saved in:
Main Authors: | Fawziah Marra, Carlo A Marra, H Grant Stiver |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2003-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2003/453183 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost Effectiveness Analysis of Azithromycin and Doxycycline for Chlamydia Trachomatis Infection in Women: A Canadian Perspective
by: Fawziah Marra, et al.
Published: (1997-01-01) -
Guidance on The Use of Antiviral Drugs for Influenza in Acute Care Facilities in Canada, 2014-2015
by: H Grant Stiver, et al.
Published: (2015-01-01) -
Outpatient Intravenous Antibiotic Therapy: The Vancouver Hospital experience
by: Grant Stiver, et al.
Published: (2000-01-01) -
Retrospective Cohort Analysis of Outpatient Antibiotic Use for Clostridioides difficile-Indicated Agents in British Columbia, from 2000 to 2018
by: Ariana Saatchi, et al.
Published: (2023-01-01) -
Pandemic Influenza and Canada's Children
by: Joanne M Langley
Published: (2006-01-01)